BR9509317A - Antagonista a interleucina-1 - Google Patents

Antagonista a interleucina-1

Info

Publication number
BR9509317A
BR9509317A BR9509317A BR9509317A BR9509317A BR 9509317 A BR9509317 A BR 9509317A BR 9509317 A BR9509317 A BR 9509317A BR 9509317 A BR9509317 A BR 9509317A BR 9509317 A BR9509317 A BR 9509317A
Authority
BR
Brazil
Prior art keywords
antagonist
interleukin
new
prophylactic
beta
Prior art date
Application number
BR9509317A
Other languages
English (en)
Inventor
Marta Muzio
Alberto Mantovani
Francesco Colotta
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of BR9509317A publication Critical patent/BR9509317A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
BR9509317A 1994-10-13 1995-10-12 Antagonista a interleucina-1 BR9509317A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI942097A IT1270662B (it) 1994-10-13 1994-10-13 Antagonista della interleuchina-1
PCT/EP1995/004023 WO1996012022A1 (en) 1994-10-13 1995-10-12 Intracellular isoform of the interleukin-1 receptor antagonist

Publications (1)

Publication Number Publication Date
BR9509317A true BR9509317A (pt) 1997-10-14

Family

ID=11369705

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9509317A BR9509317A (pt) 1994-10-13 1995-10-12 Antagonista a interleucina-1

Country Status (19)

Country Link
US (1) US5739282A (pt)
EP (1) EP0786002B1 (pt)
JP (1) JPH10509306A (pt)
KR (1) KR100237936B1 (pt)
CN (2) CN1224707C (pt)
AT (1) ATE303439T1 (pt)
BR (1) BR9509317A (pt)
CA (1) CA2202470C (pt)
DE (1) DE69534419T2 (pt)
EE (1) EE03697B1 (pt)
ES (1) ES2243942T3 (pt)
HK (2) HK1002659A1 (pt)
IT (1) IT1270662B (pt)
MX (1) MX9702616A (pt)
NO (1) NO320494B1 (pt)
PT (1) PT786002E (pt)
RU (1) RU2193064C2 (pt)
UA (1) UA65522C2 (pt)
WO (1) WO1996012022A1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075222A (en) * 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
US5872095A (en) * 1990-05-01 1999-02-16 Chiron Corporation IL-1 receptor antagonists medicaments
WO1998018823A1 (en) * 1996-10-31 1998-05-07 Applied Research Systems Ars Holding N.V. Ice inhibiting peptides
ES2312179T3 (es) * 1996-12-06 2009-02-16 Amgen Inc. Terapia combinada que utiliza un inhibidor del il-1 para el tratamiento de enfermedades mediadas por el il-1.
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
IL126562A0 (en) * 1998-10-14 1999-08-17 Interpharm Lab Ltd Expression and secretion of icil-1 receptor antagonist type ii
US20020077276A1 (en) * 1999-04-27 2002-06-20 Fredeking Terry M. Compositions and methods for treating hemorrhagic virus infections and other disorders
US7166712B2 (en) * 2000-07-12 2007-01-23 Philadelphia, Health And Education Corporation Mammalian MDM2 binding proteins and uses thereof
HUE064610T2 (hu) * 2003-12-23 2024-04-28 Genentech Inc Új anti-IL 13 antitestek és alkalmazásaik
EP1896053B1 (en) 2004-07-06 2018-10-31 ZymoGenetics, Inc. Pharmaceutical composition comprising fgf18 and il-1 antagonist and method of use
EP2217258B1 (en) 2007-11-14 2014-03-26 General Regeneratives Limited Use of interleukin-1 receptor antagonist as a myeloprotective agent
CN101690801B (zh) 2009-10-26 2012-08-01 上海交通大学 白细胞介素-1受体拮抗剂的用途及其药物组合物
ES2600616T3 (es) 2011-03-14 2017-02-10 Phlogo Aps Antagonistas del receptor de la interleucina-1
WO2013184938A2 (en) 2012-06-08 2013-12-12 Alkermes. Inc. Fusion polypeptides comprising mucin-domain polypeptide linkers
WO2015191783A2 (en) 2014-06-10 2015-12-17 Abbvie Inc. Biomarkers for inflammatory disease and methods of using same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0148009B1 (ko) * 1988-05-27 1998-08-01 그래고리 비. 아보트 인터루킨-1 억제제
HUT64582A (en) * 1989-11-29 1994-01-28 Synergen Inc Method for producing recombinant human interleukin-1 inhibitor
AU649245B2 (en) * 1990-04-02 1994-05-19 Amgen, Inc. Methods for treating interleukin-1 mediated diseases
WO1991017184A1 (en) * 1990-04-27 1991-11-14 The Upjohn Company Modified interleukin-1 inhibitors
JPH05506986A (ja) * 1990-05-01 1993-10-14 カイロン　コーポレイション インターロイキン―１拮抗物質及びその利用

Also Published As

Publication number Publication date
RU2193064C2 (ru) 2002-11-20
ITMI942097A1 (it) 1996-04-13
AU701471B2 (en) 1999-01-28
HK1081124A1 (en) 2006-05-12
US5739282A (en) 1998-04-14
NO971624D0 (no) 1997-04-09
CN1679919A (zh) 2005-10-12
HK1002659A1 (en) 1998-09-11
MX9702616A (es) 1998-04-30
ITMI942097A0 (it) 1994-10-13
CN1224707C (zh) 2005-10-26
CN100363053C (zh) 2008-01-23
WO1996012022A1 (en) 1996-04-25
EE03697B1 (et) 2002-04-15
NO320494B1 (no) 2005-12-12
EP0786002B1 (en) 2005-08-31
NO971624L (no) 1997-05-30
CA2202470A1 (en) 1996-04-25
CN1161058A (zh) 1997-10-01
JPH10509306A (ja) 1998-09-14
KR100237936B1 (ko) 2000-01-15
KR970706391A (ko) 1997-11-03
ATE303439T1 (de) 2005-09-15
EP0786002A1 (en) 1997-07-30
DE69534419T2 (de) 2006-06-14
IT1270662B (it) 1997-05-07
CA2202470C (en) 2008-09-16
AU3841795A (en) 1996-05-06
ES2243942T3 (es) 2005-12-01
UA65522C2 (en) 2004-04-15
DE69534419D1 (de) 2005-10-06
EE9700090A (et) 1997-10-15
PT786002E (pt) 2005-11-30

Similar Documents

Publication Publication Date Title
HK1081124A1 (en) Intracellular isoform of the interleukin-1 receptor antagonist
PT735818E (pt) Proteinas inflamatorias de macrofagos pim-3 pim-4 e pim-1y
DK0669979T3 (da) C-C CKR-1, kemokinreceptor
HUP9702458A2 (hu) Humán interleukin-1-receptor járulékos fehérje
DE69030582D1 (de) Herstellung eines rekombinanten menschlichen interleukin-1-hemmers
NO900227L (no) Ekstruderbar elastisk gel for anvendelse som baerer for terapeutisk middel.
ATE221125T1 (de) Klonierte glutaminsäure-decarboxylase
IL119462A (en) 1-trimethylphenyl-3-substituted 1H-pyrrol-2-amines
BR8903449A (pt) Transistor bipolar,metodo para sua fabricacao e estrutura de transistor bipolar
IT8622213A0 (it) Procedimento e dispositivo per la compressione di gas.
IT8522587A0 (it) Corpo per prove ad ultrasuoni.
ATE202483T1 (de) Immuntolerante prothrombinkomplex-präparation
IT1087288B (it) Corpo in calcestruzzo riflettente,procedimento per la sua fabbricazione e impiego del medesimo
NO970185L (no) Anvendelse av (S)-adenosyl-L-metionin (SAMe) og dets fysiologisk kompatible salter for behandling av reperfusjonsskade utlöst av temporær-fokal-ischemi
MY116362A (en) Use of selegiline for the treatment of epileptic disorders
IT8719420A0 (it) Purificazione di interleuchina-1umana ricombinante.
IT1294932B1 (it) Uso di 2-amminotetraline-6,7 sostituite per la preparazione di composizioni farmaceutiche atte al trattamento di patologie
FR2717073B1 (fr) Bac à shampoing pour malades allongés, notamment pour grabataires.
IT8920060A0 (it) Impianto per la riduzione di pressione del gas metano tra le centrali di pompaggio e le reti di distribuzione all'utenza.
IT9067565A0 (it) Procedimento per la purificazione di gas di scarico, e apparecchiatura per la sua realizzazione
IT8430791V0 (it) Dispositivo per la sincronizzazione dello schienale particolarmente per poltrone di dentisti.
IT8430790V0 (it) Dispositivo orientabile per i comandi di movimento delle poltrone particolarmente per dentisti.
IT8622527A0 (it) Procedimento per la fabbricazione di materassi e materasso ottenutocon il procedimento.
RU98114769A (ru) Способ повышения вестибулярной устойчивости человека
IT8883357A0 (it) Piedino per reti, metalliche e non, con funzioni di letto.

Legal Events

Date Code Title Description
TE Change of address
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: ESSA MATERIA NAO E PATENTEAVEL DE ACORDO COM O DISPOSTO NO ART. 229-A DA LEI 10.196 DE 14/02/2001,UMA VEZ QUE O PRESENTE PEDIDO FOI DEPOSITADO EM 12/10/1995. CABE-SE CUMPRIR O DISPOSTO NO ARTIGO DESSA LEI. DESSA FORMA, DE ACORDO COM O ART. 37, CONCLUIMOS O EXAME INDEFERINDO O PRESENTE PEDIDO COM BASE NOS ARTS. 8O, 10 (IX) E 13 DA LPI EM VIGOR BEM COMO NO ART.229-A DA LEI 10.196.